Table 1.
Total cohort (n = 11,553) | Pre-implementation (n = 5985) | Post-implementation (n = 5568) | P | |
---|---|---|---|---|
Age [years] | 69.1 ± 12.8 | 69.2 ± 12.8 | 68.9 ± 12.8 | 0.27 |
Male sex | 58.5% | 57.7% | 59.3% | 0.07 |
Admission statin | 66.2% | 64.8% | 67.7% | 0.001 |
Admission antithrombotic | 74.3% | 73.8% | 74.9% | 0.18 |